Skip to main content
Erschienen in: Aesthetic Plastic Surgery 3/2014

01.06.2014 | Original Article

Mast Cells in the Periprosthetic Breast Capsule

verfasst von: Jacqueline Brazin, Stephanie Malliaris, Brittany Groh, Babak Mehrara, David Hidalgo, David Otterburn, Randi B. Silver, Jason A. Spector

Erschienen in: Aesthetic Plastic Surgery | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Symptomatic capsular contracture occurs in about 10 % of primary breast augmentations and in more than double that rate in reconstruction after mastectomy, especially in the setting of radiation. Mast cells, traditionally associated with immune response and inflammation, secrete profibrotic mediators and may play a role in capsule formation and contracture. We analyzed the mast cell and fibroblast populations in breast capsule tissue from patients who underwent capsular excision.

Methods

Capsule tissue was collected from patients who underwent exchange of tissue expanders for permanent implants, revision of reconstruction, or revision augmentation. Breast capsule tissues were prepared for histological analyses of mast cells, fibroblasts, and collagen. Mast cells and fibroblasts were isolated from capsule tissue and screened for mediators and receptor expression.

Results

In breast capsule tissue, the average numbers of mast cells and fibroblasts were 9 ± 1/mm2 and 33 ± 10/mm2, respectively. There were significantly more mast cells on the posterior side than on the anterior side of the capsule tissue (12 ± 2 vs. 6 ± 1/mm2, p < 0.01). Baker grade IV capsules had an increased number of fibroblasts compared to Baker grade I capsules (93 ± 9 vs. 40 ± 19/mm2, p < 0.001). In breast capsule tissue, mast cells contained renin, histamine, and TGF-β, and their respective receptors, AT1R, H1R, and TGF-βRI were expressed by fibroblasts.

Conclusion

These data indicate that within breast capsule tissue mast cells contain mediators that may activate neighboring fibroblasts. Understanding the role of mast cells in pathologic periprosthetic breast capsule formation may lead to novel therapies to prevent and treat capsular contracture.

No Level Assigned

This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors http://​www.​springer.​com/​00266.
Literatur
1.
Zurück zum Zitat Shanklin DR, Smalley DL (1999) Dynamics of wound healing after silicone device implantation. Exp Mol Pathol 67:26–39PubMedCrossRef Shanklin DR, Smalley DL (1999) Dynamics of wound healing after silicone device implantation. Exp Mol Pathol 67:26–39PubMedCrossRef
2.
Zurück zum Zitat Adams WP Jr (2009) Capsular contracture: what is it? What causes it? How can it be prevented and managed? Clin Plast Surg 36(1):119–126 Adams WP Jr (2009) Capsular contracture: what is it? What causes it? How can it be prevented and managed? Clin Plast Surg 36(1):119–126
3.
Zurück zum Zitat Domanskis E, Owsley JQ Jr (1976) Histological investigation of the etiology of capsule contracture following augmentation mammaplasty. Plast Reconstr Surg 58:689–693PubMedCrossRef Domanskis E, Owsley JQ Jr (1976) Histological investigation of the etiology of capsule contracture following augmentation mammaplasty. Plast Reconstr Surg 58:689–693PubMedCrossRef
4.
Zurück zum Zitat Adams WP Jr, Haydon MS, Raniere J Jr, Trott S, Marques M, Feliciano M, Robinson JB Jr, Tang L, Brown SA (2006) A rabbit model for capsular contracture: development and clinical implications. Plast Reconstr Surg 117:1214–1219; discussion 1220–1211 Adams WP Jr, Haydon MS, Raniere J Jr, Trott S, Marques M, Feliciano M, Robinson JB Jr, Tang L, Brown SA (2006) A rabbit model for capsular contracture: development and clinical implications. Plast Reconstr Surg 117:1214–1219; discussion 1220–1211
5.
Zurück zum Zitat Katzel EB, Koltz PF, Tierney R, Williams JP, Awad HA, O’Keefe RJ, Langstein HN (2011) The impact of Smad3 loss of function on TGF-beta signaling and radiation-induced capsular contracture. Plast Reconstr Surg 127:2263–2269PubMedCrossRef Katzel EB, Koltz PF, Tierney R, Williams JP, Awad HA, O’Keefe RJ, Langstein HN (2011) The impact of Smad3 loss of function on TGF-beta signaling and radiation-induced capsular contracture. Plast Reconstr Surg 127:2263–2269PubMedCrossRef
6.
Zurück zum Zitat Prantl L, Poppl N, Horvat N, Heine N, Eisenmann-Klein M (2005) Serologic and histologic findings in patients with capsular contracture after breast augmentation with smooth silicone gel implants: is serum hyaluronan a potential predictor? Aesthetic Plast Surg 29:510–518PubMedCrossRef Prantl L, Poppl N, Horvat N, Heine N, Eisenmann-Klein M (2005) Serologic and histologic findings in patients with capsular contracture after breast augmentation with smooth silicone gel implants: is serum hyaluronan a potential predictor? Aesthetic Plast Surg 29:510–518PubMedCrossRef
7.
Zurück zum Zitat Kamel M, Protzner K, Fornasier V, Peters W, Smith D, Ibanez D (2001) The peri-implant breast capsule: an immunophenotypic study of capsules taken at explantation surgery. J Biomed Mater Res 58:88–96PubMedCrossRef Kamel M, Protzner K, Fornasier V, Peters W, Smith D, Ibanez D (2001) The peri-implant breast capsule: an immunophenotypic study of capsules taken at explantation surgery. J Biomed Mater Res 58:88–96PubMedCrossRef
8.
Zurück zum Zitat Veerappan A, Reid AC, O’Connor N, Mora R, Brazin JA, Estephan R, Kameue T, Chen J, Felsen D, Seshan SV, Poppas DP, Maack T, Silver RB (2012) Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. Am J Physiol Renal Physiol 302:F192–F204PubMedCentralPubMedCrossRef Veerappan A, Reid AC, O’Connor N, Mora R, Brazin JA, Estephan R, Kameue T, Chen J, Felsen D, Seshan SV, Poppas DP, Maack T, Silver RB (2012) Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. Am J Physiol Renal Physiol 302:F192–F204PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77:1033–1079PubMed Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77:1033–1079PubMed
10.
Zurück zum Zitat Kuhn A, Singh S, Smith PD, Ko F, Falcone R, Lyle WG, Maggi SP, Wells KE, Robson MC (2000) Periprosthetic breast capsules contain the fibrogenic cytokines TGF-beta1 and TGF-beta2, suggesting possible new treatment approaches. Ann Plast Surg 44:387–391PubMedCrossRef Kuhn A, Singh S, Smith PD, Ko F, Falcone R, Lyle WG, Maggi SP, Wells KE, Robson MC (2000) Periprosthetic breast capsules contain the fibrogenic cytokines TGF-beta1 and TGF-beta2, suggesting possible new treatment approaches. Ann Plast Surg 44:387–391PubMedCrossRef
11.
Zurück zum Zitat Baker JL Jr, Chandler ML, LeVier RR (1981) Occurrence and activity of myofibroblasts in human capsular tissue surrounding mammary implants. Plast Reconstr Surg 68:905–912PubMedCrossRef Baker JL Jr, Chandler ML, LeVier RR (1981) Occurrence and activity of myofibroblasts in human capsular tissue surrounding mammary implants. Plast Reconstr Surg 68:905–912PubMedCrossRef
12.
Zurück zum Zitat Jordana M, Befus AD, Newhouse MT, Bienenstock J, Gauldie J (1988) Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 43:552–558PubMedCentralPubMedCrossRef Jordana M, Befus AD, Newhouse MT, Bienenstock J, Gauldie J (1988) Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 43:552–558PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Mezzano SA, Ruiz-Ortega M, Egido J (2001) Angiotensin II and renal fibrosis. Hypertension 38:635–638PubMedCrossRef Mezzano SA, Ruiz-Ortega M, Egido J (2001) Angiotensin II and renal fibrosis. Hypertension 38:635–638PubMedCrossRef
14.
Zurück zum Zitat Veerappan A, Reid AC, Estephan R, O’Connor N, Thadani-Mulero M, Salazar-Rodriguez M, Levi R, Silver RB (2008) Mast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstriction. Proc Natl Acad Sci U S A 105:1315–1320PubMedCentralPubMedCrossRef Veerappan A, Reid AC, Estephan R, O’Connor N, Thadani-Mulero M, Salazar-Rodriguez M, Levi R, Silver RB (2008) Mast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstriction. Proc Natl Acad Sci U S A 105:1315–1320PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Silver RB, Reid AC, Brazin JA, Levi R (2010) Mast cells, local renin-angiotensin system and cardiovascular disease. In: Joseph J (ed) Mast Cells and Cardiovascular Disease. Nova Science Publishers, New York, pp 5–32 Silver RB, Reid AC, Brazin JA, Levi R (2010) Mast cells, local renin-angiotensin system and cardiovascular disease. In: Joseph J (ed) Mast Cells and Cardiovascular Disease. Nova Science Publishers, New York, pp 5–32
16.
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
17.
Zurück zum Zitat Bergstresser PR, Tigelaar RE, Tharp MD (1984) Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 83:214–218PubMedCrossRef Bergstresser PR, Tigelaar RE, Tharp MD (1984) Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 83:214–218PubMedCrossRef
18.
Zurück zum Zitat Samoszuk M, Kanakubo E, Chan J (2005) Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 5:121PubMedCentralPubMedCrossRef Samoszuk M, Kanakubo E, Chan J (2005) Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 5:121PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Janssens AS, Heide R, den Hollander JC, Mulder PG, Tank B, Oranje AP (2005) Mast cell distribution in normal adult skin. J Clin Pathol 58:285–289PubMedCentralPubMedCrossRef Janssens AS, Heide R, den Hollander JC, Mulder PG, Tank B, Oranje AP (2005) Mast cell distribution in normal adult skin. J Clin Pathol 58:285–289PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R (2004) Mast cells: a unique source of renin. Proc Natl Acad Sci U S A 101:13607–13612PubMedCentralPubMedCrossRef Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R (2004) Mast cells: a unique source of renin. Proc Natl Acad Sci U S A 101:13607–13612PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R (2006) Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 116:1063–1070PubMedCentralPubMedCrossRef Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R (2006) Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 116:1063–1070PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Simoneau B, Lavallee P, Anderson PC, Bailey M, Bantle G, Berthiaume S, Chabot C, Fazal G, Halmos T, Ogilvie WW, Poupart MA, Thavonekham B, Xin Z, Thibeault D, Bolger G, Panzenbeck M, Winquist R, Jung GL (1999) Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy. Bioorg Med Chem 7:489–508PubMedCrossRef Simoneau B, Lavallee P, Anderson PC, Bailey M, Bantle G, Berthiaume S, Chabot C, Fazal G, Halmos T, Ogilvie WW, Poupart MA, Thavonekham B, Xin Z, Thibeault D, Bolger G, Panzenbeck M, Winquist R, Jung GL (1999) Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy. Bioorg Med Chem 7:489–508PubMedCrossRef
23.
Zurück zum Zitat Little G, Baker JL Jr (1980) Results of closed compression capsulotomy for treatment of contracted breast implant capsules. Plast Reconstr Surg 65:30–33PubMedCrossRef Little G, Baker JL Jr (1980) Results of closed compression capsulotomy for treatment of contracted breast implant capsules. Plast Reconstr Surg 65:30–33PubMedCrossRef
24.
Zurück zum Zitat Veerappan A, O’Connor N, Brazin J, Reid AC, Jung A, McGee D, Summers B, Branch-Elliman D, Stiles B, Worgall S, Kaner RJ, Silver RB (2013) Mast cells: a pivotal role in pulmonary fibrosis. DNA Cell Biol 32:206–218PubMedCentralPubMedCrossRef Veerappan A, O’Connor N, Brazin J, Reid AC, Jung A, McGee D, Summers B, Branch-Elliman D, Stiles B, Worgall S, Kaner RJ, Silver RB (2013) Mast cells: a pivotal role in pulmonary fibrosis. DNA Cell Biol 32:206–218PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Thevenot PT, Baker DW, Weng H, Sun MW, Tang L (2011) The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials. Biomaterials 32:8394–8403PubMedCentralPubMedCrossRef Thevenot PT, Baker DW, Weng H, Sun MW, Tang L (2011) The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials. Biomaterials 32:8394–8403PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Zimman OA, Toblli J, Stella I, Ferder M, Ferder L, Inserra F (2007) The effects of angiotensin-converting-enzyme inhibitors on the fibrous envelope around mammary implants. Plast Reconstr Surg 120:2025–2033PubMedCrossRef Zimman OA, Toblli J, Stella I, Ferder M, Ferder L, Inserra F (2007) The effects of angiotensin-converting-enzyme inhibitors on the fibrous envelope around mammary implants. Plast Reconstr Surg 120:2025–2033PubMedCrossRef
Metadaten
Titel
Mast Cells in the Periprosthetic Breast Capsule
verfasst von
Jacqueline Brazin
Stephanie Malliaris
Brittany Groh
Babak Mehrara
David Hidalgo
David Otterburn
Randi B. Silver
Jason A. Spector
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Aesthetic Plastic Surgery / Ausgabe 3/2014
Print ISSN: 0364-216X
Elektronische ISSN: 1432-5241
DOI
https://doi.org/10.1007/s00266-014-0318-2

Weitere Artikel der Ausgabe 3/2014

Aesthetic Plastic Surgery 3/2014 Zur Ausgabe

Editor's Invited Commentary

Suspension Sutures for Neck Rejuvenation

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.